Kiran Kumar Kolathur

Dr. Kiran Kumar Kolathur

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in European Journal of Pharmacology
Verified
Journal Article
Open access
SSSairaj Satarker
Sairaj Satarker
JWJoel Wilson
Joel Wilson
KKKiran Kumar Kolathur
Kiran Kumar Kolathur
JMJayesh Mudgal
Jayesh Mudgal
SLShaila A. Lewis
Shaila A. Lewis
MGMADHAVAN NAMPOOTHIRI G
MADHAVAN NAMPOOTHIRI G
Autophagy is an abnormal protein degradation and recycling process that is impaired in various neurological diseases like Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease. Spermidine is a natural polyamine found in various plant- and meat-based diets that can induce autophagy, and is decreased in various neurodegenerative diseases. It acts on epigenetic enzymes like E1A-binding protein p300, HAT enzymes like Iki3p and Sas3p, and α-tubulin acetyltransferase 1 that modulate autophagy. Histone modifications like acetylation, phosphorylation, and methylation could influence autophagy. Autophagy is epigenetically regulated in various neurodegenerative disorders with many epigenetic enzymes and miRNAs. Polyamine regulation plays an essential role in the disease pathogenesis of AD and PD. Therefore, in this review, we discuss various enzymes and miRNAs involved in the epigenetic regulation of autophagy in neurodegenerative disorders and the role of spermidine as an autophagy enhancer. The alterations in spermidine-mediated regulation of Beclin-1, LC3-II, and p62 genes in AD and other PD-associated enzymes could impact the process of autophagy in these neurodegenerative diseases. With the ever-growing data and such promising effects of spermidine in autophagy, we feel it could be a promising target in this area and worth further detailed studies.

25 September 2017 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
PTPoonam Thakran
Poonam Thakran
PPPrashant Arun Pandit
Prashant Arun Pandit
SDSumanjit Datta
Sumanjit Datta
KKKiran Kumar Kolathur
Kiran Kumar Kolathur
JPJeffrey A Pleiss
Jeffrey A Pleiss
SMShravan Kumar Mishra
Shravan Kumar Mishra

1 May 2021 in Gene
Verified
Journal Article
Closed access
KKKiran Kumar Kolathur
Kiran Kumar Kolathur

12 May 2025 in Cancer Biology & Therapy
Verified
Journal Article
Open access
SMSandeep Mallya
Sandeep Mallya
VGVarsha Gangadhar
Varsha Gangadhar
SASophia Evangeline Aldrin
Sophia Evangeline Aldrin
MAMeghana Acharya
Meghana Acharya
SKShama Prasada Kabekkodu
Shama Prasada Kabekkodu
Sanjiban ChakrabartySanjiban Chakrabarty
Sanjiban Chakrabarty
The epidemic of obesity is a growing concern and is one of the major risk factors for several chronic diseases, including several types of cancers. The correlation of breast cancer with obesity has been extensively studied and involves an interplay of hormonal, metabolic, and genetic factors explored in this review. Inflammation and hormone dysregulation play an important role in promoting a protumorigenic environment through adipose tissue, which is involved in energy storage and functions as an endocrine organ. As a result, various cytokines, primarily proinflammatory in nature, are released, resulting in low-grade inflammation promoting tumor growth. Additionally, obese conditions also induce imbalances in hormones, particularly estrogen and insulin, both of which drive carcinogenesis. Genetic components such as single nucleotide polymorphisms also play critical roles in modulating the correlation between obesity and breast cancer. This review provides a comprehensive overview of various mechanisms underlying obesity and breast cancer incidence and progression.

20 August 2024 in Cells
Verified
Journal Article
Open access
PDF file
KKKiran Kumar Kolathur
Kiran Kumar Kolathur
RNRadhakanta Nag
Radhakanta Nag
PSPrathvi V Shenoy
Prathvi V Shenoy
YMYagya Malik
Yagya Malik
SVSai Manasa Varanasi
Sai Manasa Varanasi
Debabrata MukhopadhyayDebabrata Mukhopadhyay
Debabrata Mukhopadhyay
Melanoma is the most aggressive subtype of cancer, with a higher propensity to spread compared to most solid tumors. The application of OMICS approaches has revolutionized the field of melanoma research by providing comprehensive insights into the molecular alterations and biological processes underlying melanoma development and progression. This review aims to offer an overview of melanoma biology, covering its transition from primary to malignant melanoma, as well as the key genes and pathways involved in the initiation and progression of this disease. Utilizing online databases, we extensively explored the general expression profile of genes, identified the most frequently altered genes and gene mutations, and examined genetic alterations responsible for drug resistance. Additionally, we studied the mechanisms responsible for immune checkpoint inhibitor resistance in melanoma.

19 December 2022 in FEBS Letters
Verified
Journal Article
Open access
PDF file
KKKiran Kumar Kolathur
Kiran Kumar Kolathur
PSPallavi Sharma
Pallavi Sharma
NKNagesh Y. Kadam
Nagesh Y. Kadam
NSNavneet Shahi
Navneet Shahi
ANAne Nishitha
Ane Nishitha
SMShravan Kumar Mishra
Shravan Kumar Mishra
The ubiquitin‐like protein Hub1/UBL‐5 associates with proteins non‐covalently. Hub1 promotes alternative splicing and splicing of precursor mRNAs with weak introns in yeast and mammalian cells; however, its splicing function has remained elusive in multicellular organisms. Here, we demonstrate the splicing function of Hub1/UBL‐5 in the free‐living nematode Caenorhabditis elegans. Hub1/UBL‐5 binds to the HIND‐containing splicing factors Snu66/SART‐1 and PRP‐38 and associates with other spliceosomal proteins. C. elegans hub1/ubl‐5 mutants die at the Larval 3 stage and show splicing defects for selected targets, similar to the mutants in yeast and mammalian cells. UBL‐5 complemented growth and splicing defects in Schizosaccharomyces pombe hub1 mutants, confirming its functional conservation. Thus, UBL‐5 is important for C. elegans development and plays a conserved pre‐mRNA splicing function.